A possible explanation for why many cancer drugs that kill
SwiftScale Biologics: Cell-Free Synthesis of Biologics
insights from industryDavid MaceChief Executive OfficerSwiftScale Biologics In this interview,
New treatment for life-threatening lung condition receives NSF award
A Purdue University-affiliated startup developing a novel treatment for a
Project Helios launched to unlock new approaches in small molecule drug discovery
The University of Texas MD Anderson Cancer Center's Therapeutics Discovery
CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
NEWARK, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics,
Stem cells can differentiate into neurons and may be useful post-stroke therapeutics
Researchers have performed a careful comparison between locally generated, ischemia-induced,
Menlo Therapeutics Announces Results from a Phase 2 Clinical Trial of Serlopitant for the Treatment of Refractory Chronic Cough
REDWOOD CITY, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) — Menlo